# Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8

> **NCT00218036** · PHASE2 · TERMINATED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 54 (actual)

## Conditions studied

- Cocaine Abuse
- Opiate Dependence

## Interventions

- **DRUG:** Modafinil 200mg
- **DRUG:** Modafinil 400mg
- **DRUG:** Citalopram 20mg
- **DRUG:** Citalopram 40mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00218036
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-07
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 54 (ACTUAL)
- **Why stopped:** PI left institution, end of funding, clinic relocation, recruitment issues
- **Last updated:** 2018-11-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00218036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00218036, "Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00218036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*